Loading...

Hamid Moradi

Title(s)Associate Clinical Professor, Medicine
Address1001 Health Sciences Road
Irvine CA 92697-3950
Phone(714) 456-5560, 5142, 66
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    HDL function and mortality in end stage renal disease
    NIH IK2CX001043Jan 1, 2015 - Dec 31, 2020
    Role: Principal Investigator
    Mechanisms involved in uremic toxin mediated down regulation of ApoA-I expression
    NIH F32DK082130Jul 1, 2009 - Jun 30, 2013
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Impact of Circulating N-Acylethanolamine Levels with Clinical and Laboratory End Points in Hemodialysis Patients. Am J Nephrol. 2021 Feb 18; 1-10. Pai AY, Wenziger C, Streja E, Argueta DA, DiPatrizio NV, Rhee CM, Vaziri ND, Kalantar-Zadeh K, Piomelli D, Moradi H. PMID: 33601382.
      View in: PubMed   Mentions:    Fields:    
    2. Evaluation of vitamin D levels in COVID-19 patients referred to Labafinejad hospital in Tehran and its relationship with disease severity and mortality. Clin Nutr ESPEN. 2021 04; 42:313-317. Tehrani S, Khabiri N, Moradi H, Mosavat MS, Khabiri SS. PMID: 33745598.
      View in: PubMed   Mentions:
    3. Association of lactate dehydrogenase with mortality in incident hemodialysis patients. Nephrol Dial Transplant. 2020 Dec 26. Ryu SY, Kleine CE, Hsiung JT, Park C, Rhee CM, Moradi H, Hanna R, Kalantar-Zadeh K, Streja E. PMID: 33367881.
      View in: PubMed   Mentions:    Fields:    
    4. RNAi targeting liver Angiopoietin-like protein 3 protects from nephrotic syndrome in a rat model via amelioration of pathologic hypertriglyceridemia. J Pharmacol Exp Ther. 2020 Dec 18. Zhao Y, Goto M, Vaziri ND, Khazaeli M, Liu H, Farahanchi N, Khanifar E, Farzaneh T, Haslett PA, Moradi H, Soundarapandian MM. PMID: 33443084.
      View in: PubMed   Mentions:    Fields:    
    5. Hemodynamic and Laboratory Changes during Incremental Transition from Twice to Thrice-Weekly Hemodialysis. Cardiorenal Med. 2020; 10(2):97-107. Hur I, Wenziger C, Obi Y, Moradi H, Streja E, Tantisattamo E, Choi SJ, Lau WL, Chang Y, Jin A, Chen JLT, Kovesdy CP, Rhee CM, Kalantar-Zadeh K. PMID: 31935740.
      View in: PubMed   Mentions:    Fields:    
    6. Circulating Endocannabinoids and Mortality in Hemodialysis Patients. Am J Nephrol. 2020; 51(2):86-95. Moradi H, Park C, Streja E, Argueta DA, DiPatrizio NV, You AS, Rhee CM, Vaziri ND, Kalantar-Zadeh K, Piomelli D. PMID: 31935741.
      View in: PubMed   Mentions: 1     Fields:    
    7. Association of Serum Paraoxonase/Arylesterase Activity With All-Cause Mortality in Maintenance Hemodialysis Patients. J Clin Endocrinol Metab. 2019 10 01; 104(10):4848-4856. Suematsu Y, Goto M, Park C, Nunes ACF, Jing W, Streja E, Rhee CM, Cruz S, Kashyap ML, Vaziri ND, Narayanaswami V, Kalantar-Zadeh K, Moradi H. PMID: 30920627.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    8. Serum triglycerides and mortality risk across stages of chronic kidney disease in 2 million U.S. veterans. J Clin Lipidol. 2019 Sep - Oct; 13(5):744-753.e15. Soohoo M, Moradi H, Obi Y, Kovesdy CP, Kalantar-Zadeh K, Streja E. PMID: 31562050.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    9. Serum Endocannabinoid Levels in Patients With End-Stage Renal Disease. J Endocr Soc. 2019 Oct 01; 3(10):1869-1880. Moradi H, Park C, Igarashi M, Streja E, Argueta DA, Soohoo M, Daglian J, You AS, Rhee CM, Kashyap ML, DiPatrizio NV, Vaziri ND, Kalantar-Zadeh K, Piomelli D. PMID: 31583368.
      View in: PubMed   Mentions:
    10. Statin Therapy Before Transition to End-Stage Renal Disease With Posttransition Outcomes. J Am Heart Assoc. 2019 03 19; 8(6):e011869. Soohoo M, Moradi H, Obi Y, Rhee CM, Gosmanova EO, Molnar MZ, Kashyap ML, Gillen DL, Kovesdy CP, Kalantar-Zadeh K, Streja E. PMID: 30885048.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. Endocannabinoid System and the Kidneys: From Renal Physiology to Injury and Disease. Cannabis Cannabinoid Res. 2019; 4(1):10-20. Chua JT, Argueta DA, DiPatrizio NV, Kovesdy CP, Vaziri ND, Kalantar-Zadeh K, Moradi H. PMID: 31346545.
      View in: PubMed   Mentions:
    12. Association of Pre-End-Stage Renal Disease Serum Albumin With Post-End-Stage Renal Disease Outcomes Among Patients Transitioning to Dialysis. J Ren Nutr. 2019 07; 29(4):310-321. Hsiung JT, Kleine CE, Naderi N, Park C, Soohoo M, Moradi H, Rhee CM, Obi Y, Kopple JD, Kovesdy CP, Kalantar-Zadeh K, Streja E. PMID: 30642656.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Emerging paradigms of treating diabetic nephropathy. Lancet Diabetes Endocrinol. 2018 12; 6(12):912-913. Chang Y, Moradi H, Kalantar-Zadeh K. PMID: 30413395.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    14. Racial and Ethnic Disparities in the Obesity Paradox. Am J Kidney Dis. 2018 11; 72(5 Suppl 1):S26-S32. Kleine CE, Moradi H, Streja E, Kalantar-Zadeh K. PMID: 30343719.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    15. Association of Continuation of Statin Therapy Initiated Before Transition to Chronic Dialysis Therapy With Mortality After Dialysis Initiation. JAMA Netw Open. 2018 10 05; 1(6):e182311. Streja E, Gosmanova EO, Molnar MZ, Soohoo M, Moradi H, Potukuchi PK, Kalantar-Zadeh K, Kovesdy CP. PMID: 30646217.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    16. Obesity Paradox in Advanced Kidney Disease: From Bedside to the Bench. Prog Cardiovasc Dis. 2018 Jul - Aug; 61(2):168-181. Naderi N, Kleine CE, Park C, Hsiung JT, Soohoo M, Tantisattamo E, Streja E, Kalantar-Zadeh K, Moradi H. PMID: 29981348.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimals
    17. Precision Medicine and Personalized Management of Lipoprotein and Lipid Disorders in Chronic and End-Stage Kidney Disease. Semin Nephrol. 2018 07; 38(4):369-382. Streja E, Streja DA, Soohoo M, Kleine CE, Hsiung JT, Park C, Moradi H. PMID: 30082057.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    18. Introduction: Precision Medicine in End-Stage Kidney Disease and Personalized Renal Replacement Therapy: Challenges and Unmet Need. Semin Nephrol. 2018 07; 38(4):315-316. Moradi H, Kalantar-Zadeh K. PMID: 30082051.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    19. Inverse Association Between Serum Non-High-Density Lipoprotein Cholesterol Levels and Mortality in Patients Undergoing Incident Hemodialysis. J Am Heart Assoc. 2018 06 09; 7(12). Chang TI, Streja E, Ko GJ, Naderi N, Rhee CM, Kovesdy CP, Kashyap ML, Vaziri ND, Kalantar-Zadeh K, Moradi H. PMID: 29886420.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    20. Association of Pre-End-Stage Renal Disease Hemoglobin with Early Dialysis Outcomes. Am J Nephrol. 2018; 47(5):333-342. Kleine CE, Soohoo M, Ranasinghe ON, Park C, Marroquin MV, Obi Y, Rhee CM, Moradi H, Kovesdy CP, Kalantar-Zadeh K, Streja E. PMID: 29779027.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    21. ESRD-induced dyslipidemia-Should management of lipid disorders differ in dialysis patients? Semin Dial. 2018 07; 31(4):398-405. Moradi H, Streja E, Vaziri ND. PMID: 29707830.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    22. Increments in serum high-density lipoprotein cholesterol over time are not associated with improved outcomes in incident hemodialysis patients. J Clin Lipidol. 2018 Mar - Apr; 12(2):488-497. Chang TI, Streja E, Soohoo M, Ko GJ, Rhee CM, Kovesdy CP, Kashyap ML, Vaziri ND, Kalantar-Zadeh K, Moradi H. PMID: 29456130.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    23. LCZ696 (Sacubitril/Valsartan), an Angiotensin-Receptor Neprilysin Inhibitor, Attenuates Cardiac Hypertrophy, Fibrosis, and Vasculopathy in a Rat Model of Chronic Kidney Disease. J Card Fail. 2018 Apr; 24(4):266-275. Suematsu Y, Jing W, Nunes A, Kashyap ML, Khazaeli M, Vaziri ND, Moradi H. PMID: 29325796.
      View in: PubMed   Mentions: 14     Fields:    Translation:Animals
    24. LCZ696 (Sacubitril/valsartan) ameliorates oxidative stress, inflammation, fibrosis and improves renal function beyond angiotensin receptor blockade in CKD. Am J Transl Res. 2017; 9(12):5473-5484. Jing W, Vaziri ND, Nunes A, Suematsu Y, Farzaneh T, Khazaeli M, Moradi H. PMID: 29312499.
      View in: PubMed   Mentions:
    25. Serum high density lipoprotein cholesterol level and risk of death: let's avoid the extremes. J Thorac Dis. 2017 Dec; 9(12):4849-4852. Moradi H, Streja E, Kalantar-Zadeh K. PMID: 29312674.
      View in: PubMed   Mentions:
    26. Inhibition of intestinal ascorbic acid uptake by lipopolysaccharide is mediated via transcriptional mechanisms. Biochim Biophys Acta Biomembr. 2018 Feb; 1860(2):556-565. Subramanian VS, Sabui S, Moradi H, Marchant JS, Said HM. PMID: 29030247.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    27. Association of serum vitamin B12 and folate with mortality in incident hemodialysis patients. Nephrol Dial Transplant. 2017 Jun 01; 32(6):1024-1032. Soohoo M, Ahmadi SF, Qader H, Streja E, Obi Y, Moradi H, Rhee CM, Kim TH, Kovesdy CP, Kalantar-Zadeh K. PMID: 27190367.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    28. Could high-density lipoprotein cholesterol predict increased cardiovascular risk? Curr Opin Endocrinol Diabetes Obes. 2017 Apr; 24(2):140-147. Chang TI, Streja E, Moradi H. PMID: 28099207.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    29. Association of Serum Triglyceride to HDL Cholesterol Ratio with All-Cause and Cardiovascular Mortality in Incident Hemodialysis Patients. Clin J Am Soc Nephrol. 2017 Apr 03; 12(4):591-602. Chang TI, Streja E, Soohoo M, Kim TW, Rhee CM, Kovesdy CP, Kashyap ML, Vaziri ND, Kalantar-Zadeh K, Moradi H. PMID: 28193609.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    30. Increased Renal 2-Arachidonoylglycerol Level Is Associated with Improved Renal Function in a Mouse Model of Acute Kidney Injury. Cannabis Cannabinoid Res. 2016; 1(1):218-228. Moradi H, Oveisi F, Khanifar E, Moreno-Sanz G, Vaziri ND, Piomelli D. PMID: 28861493.
      View in: PubMed   Mentions:
    31. Functional thiamine deficiency in end-stage renal disease: malnutrition despite ample nutrients. Kidney Int. 2016 08; 90(2):252-254. Moradi H, Said HM. PMID: 27418090.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    32. Effect of resveratrol on progression of polycystic kidney disease: a case of cautious optimism. Nephrol Dial Transplant. 2016 11; 31(11):1755-1758. Moradi H, Vaziri ND. PMID: 27190353.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    33. Red Cell Distribution Width and Mortality in Hemodialysis Patients. Am J Kidney Dis. 2016 Jul; 68(1):110-21. Vashistha T, Streja E, Molnar MZ, Rhee CM, Moradi H, Soohoo M, Kovesdy CP, Kalantar-Zadeh K. PMID: 26786297.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    34. Examining the robustness of the obesity paradox in maintenance hemodialysis patients: a marginal structural model analysis. Nephrol Dial Transplant. 2016 08; 31(8):1310-9. Doshi M, Streja E, Rhee CM, Park J, Ravel VA, Soohoo M, Moradi H, Lau WL, Mehrotra R, Kuttykrishnan S, Kovesdy CP, Kalantar-Zadeh K, Chen JL. PMID: 26590266.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    35. Reverse Epidemiology of Traditional Cardiovascular Risk Factors in the Geriatric Population. J Am Med Dir Assoc. 2015 Nov 01; 16(11):933-9. Ahmadi SF, Streja E, Zahmatkesh G, Streja D, Kashyap M, Moradi H, Molnar MZ, Reddy U, Amin AN, Kovesdy CP, Kalantar-Zadeh K. PMID: 26363864.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    36. Association of aspartate aminotransferase with mortality in hemodialysis patients. Nephrol Dial Transplant. 2016 05; 31(5):814-22. Ravel V, Streja E, Molnar MZ, Rezakhani S, Soohoo M, Kovesdy CP, Kalantar-Zadeh K, Moradi H. PMID: 26333544.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    37. Association of serum lipids with outcomes in Hispanic hemodialysis patients of the West versus East Coasts of the United States. Am J Nephrol. 2015; 41(4-5):284-95. Moradi H, Abhari P, Streja E, Kashyap ML, Shah G, Gillen D, Pahl MV, Vaziri ND, Kalantar-Zadeh K. PMID: 26044456.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    38. Association of Adiponectin With Body Composition and Mortality in Hemodialysis Patients. Am J Kidney Dis. 2015 Aug; 66(2):313-21. Rhee CM, Nguyen DV, Moradi H, Brunelli SM, Dukkipati R, Jing J, Nakata T, Kovesdy CP, Brent GA, Kalantar-Zadeh K. PMID: 25824125.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    39. Niacin and progression of CKD. Am J Kidney Dis. 2015 May; 65(5):785-98. Streja E, Kovesdy CP, Streja DA, Moradi H, Kalantar-Zadeh K, Kashyap ML. PMID: 25708553.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    40. Dietary restrictions in dialysis patients: is there anything left to eat? Semin Dial. 2015 Mar-Apr; 28(2):159-68. Kalantar-Zadeh K, Tortorici AR, Chen JL, Kamgar M, Lau WL, Moradi H, Rhee CM, Streja E, Kovesdy CP. PMID: 25649719.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    41. Cerebral microbleeds and cognitive decline in a hemodialysis patient: Case report and review of literature. Hemodial Int. 2015 Jul; 19(3):E1-7. Li L, Fisher M, Lau WL, Moradi H, Cheung A, Thai G, Handwerker J, Kalantar-Zadeh K. PMID: 25175449.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    42. Dual role of circulating angiopoietin-like 4 (ANGPTL4) in promoting hypertriglyceridemia and lowering proteinuria in nephrotic syndrome. Am J Kidney Dis. 2014 Oct; 64(4):495-8. Vaziri ND, Moradi H. PMID: 24838183.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    43. Elevated high-density lipoprotein cholesterol and cardiovascular mortality in maintenance hemodialysis patients. Nephrol Dial Transplant. 2014 Aug; 29(8):1554-62. Moradi H, Streja E, Kashyap ML, Vaziri ND, Fonarow GC, Kalantar-Zadeh K. PMID: 24574544.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    44. Impact of age, race and ethnicity on dialysis patient survival and kidney transplantation disparities. Am J Nephrol. 2014; 39(3):183-94. Rhee CM, Lertdumrongluk P, Streja E, Park J, Moradi H, Lau WL, Norris KC, Nissenson AR, Amin AN, Kovesdy CP, Kalantar-Zadeh K. PMID: 24556752.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    45. Iron indices and survival in maintenance hemodialysis patients with and without polycystic kidney disease. Nephrol Dial Transplant. 2013 Nov; 28(11):2889-98. Hatamizadeh P, Ravel V, Lukowsky LR, Molnar MZ, Moradi H, Harley K, Pahl M, Kovesdy CP, Kalantar-Zadeh K. PMID: 24169614.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    46. Renoprotective mechanisms of ischemic postconditioning in ischemia-reperfusion injury: improved mitochondrial function and integrity. Nephrol Dial Transplant. 2013 Nov; 28(11):2667-9. Moradi H, Wang PH. PMID: 24169608.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    47. Cardiovascular burden associated with uremic toxins in patients with chronic kidney disease. Am J Nephrol. 2013; 38(2):136-48. Moradi H, Sica DA, Kalantar-Zadeh K. PMID: 23941724.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansAnimalsCells
    48. Skeletal muscle mitochondrial depletion and dysfunction in chronic kidney disease. Int J Clin Exp Med. 2013; 6(7):532-9. Yazdi PG, Moradi H, Yang JY, Wang PH, Vaziri ND. PMID: 23936591.
      View in: PubMed   Mentions:
    49. Role of HDL dysfunction in end-stage renal disease: a double-edged sword. J Ren Nutr. 2013 May; 23(3):203-6. Moradi H, Vaziri ND, Kashyap ML, Said HM, Kalantar-Zadeh K. PMID: 23611547.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    50. Association of serum phosphorus concentration with mortality in elderly and nonelderly hemodialysis patients. J Ren Nutr. 2013 Nov; 23(6):411-21. Lertdumrongluk P, Rhee CM, Park J, Lau WL, Moradi H, Jing J, Molnar MZ, Brunelli SM, Nissenson AR, Kovesdy CP, Kalantar-Zadeh K. PMID: 23631888.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    51. Glyoxalate reductase/hydroxypyruvate reductase interacts with the sodium-dependent vitamin C transporter-1 to regulate cellular vitamin C homeostasis. Am J Physiol Gastrointest Liver Physiol. 2013 Jun 15; 304(12):G1079-86. Subramanian VS, Nabokina SM, Patton JR, Marchant JS, Moradi H, Said HM. PMID: 23599041.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    52. Hepatic fatty acid and cholesterol metabolism in nephrotic syndrome. Am J Transl Res. 2013; 5(2):246-53. Han S, Vaziri ND, Gollapudi P, Kwok V, Moradi H. PMID: 23573368.
      View in: PubMed   Mentions:
    53. Post-transcriptional nature of uremia-induced downregulation of hepatic apolipoprotein A-I production. Transl Res. 2013 Jun; 161(6):477-85. Moradi H, Said HM, Vaziri ND. PMID: 23219399.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    54. Uremic plasma impairs barrier function and depletes the tight junction protein constituents of intestinal epithelium. Am J Nephrol. 2012; 36(5):438-43. Vaziri ND, Goshtasbi N, Yuan J, Jellbauer S, Moradi H, Raffatellu M, Kalantar-Zadeh K. PMID: 23128155.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCells
    55. Salutary effects of hemodialysis on low-density lipoprotein proinflammatory and high-density lipoprotein anti-inflammatory properties in patient with end-stage renal disease. J Natl Med Assoc. 2011 Jun; 103(6):524-33. Vaziri ND, Navab K, Gollapudi P, Moradi H, Pahl MV, Barton CH, Fogelman AM, Navab M. PMID: 21830637.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    56. Nephrotic syndrome causes upregulation of HDL endocytic receptor and PDZK-1-dependent downregulation of HDL docking receptor. Nephrol Dial Transplant. 2011 Oct; 26(10):3118-23. Vaziri ND, Gollapudi P, Han S, Farahmand G, Yuan J, Rahimi A, Moradi H. PMID: 21459782.
      View in: PubMed   Mentions: 8     Fields:    Translation:AnimalsCells
    57. Increased monocyte adhesion-promoting capacity of plasma in end-stage renal disease - response to antioxidant therapy. Clin Nephrol. 2010 Oct; 74(4):273-81. Moradi H, Ganji S, Kamanna V, Pahl MV, Vaziri ND. PMID: 20875379.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    58. Amelioration of nephropathy with apoA-1 mimetic peptide in apoE-deficient mice. Nephrol Dial Transplant. 2010 Nov; 25(11):3525-34. Vaziri ND, Kim HJ, Moradi H, Farmand F, Navab K, Navab M, Hama S, Fogelman AM, Quiroz Y, Rodriguez-Iturbe B. PMID: 20488818.
      View in: PubMed   Mentions: 7     Fields:    Translation:Animals
    59. In vitro stimulation of HDL anti-inflammatory activity and inhibition of LDL pro-inflammatory activity in the plasma of patients with end-stage renal disease by an apoA-1 mimetic peptide. Kidney Int. 2009 Aug; 76(4):437-44. Vaziri ND, Moradi H, Pahl MV, Fogelman AM, Navab M. PMID: 19471321.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCells
    60. Reverse cholesterol transport pathway in experimental chronic renal failure. Am J Nephrol. 2009; 30(2):147-54. Moradi H, Yuan J, Ni Z, Norris K, Vaziri ND. PMID: 19321994.
      View in: PubMed   Mentions: 15     Fields:    Translation:AnimalsCells
    61. Plasma phospholipid transfer protein, cholesteryl ester transfer protein and lecithin:cholesterol acyltransferase in end-stage renal disease (ESRD). Nephrol Dial Transplant. 2009 Aug; 24(8):2541-6. Pahl MV, Ni Z, Sepassi L, Moradi H, Vaziri ND. PMID: 19297356.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    62. Impaired antioxidant activity of high-density lipoprotein in chronic kidney disease. Transl Res. 2009 Feb; 153(2):77-85. Moradi H, Pahl MV, Elahimehr R, Vaziri ND. PMID: 19138652.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansCells
    63. Effect of chronic renal failure on arginase and argininosuccinate synthetase expression. Am J Nephrol. 2006; 26(3):310-8. Moradi H, Kwok V, Vaziri ND. PMID: 16809898.
      View in: PubMed   Mentions: 6     Fields:    Translation:AnimalsCells
    64. Mechanisms of dyslipidemia of chronic renal failure. Hemodial Int. 2006 Jan; 10(1):1-7. Vaziri ND, Moradi H. PMID: 16441821.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    Hamid's Networks
    Concepts (238)
    Derived automatically from this person's publications.
    _
    Co-Authors (22)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _